Blockman, MCohen, KDe Waal, RGray, AKredo, TMaartens, GNel, JParrish, ARees, HReubenson, G2024-10-042024-10-042020-05-27https://hdl.handle.net/11288/597708The BCG vaccine, a live attenuated strain of Mycobacterium bovis, was first used in humans in 19211. BCG vaccination was introduced in South Africa in 1973 and is given intradermally at birth using the Danish BCG strain2. There are several strains of the vaccine, which have different microbiological properties.enAttribution 3.0 United Stateshttp://creativecommons.org/licenses/by/3.0/us/Bacille Calmette-GuerinVaccine for SARS-Cov-2BGC vaccineCOVID-19 PreventionVaccine for COVID-19COVID-19 treatmentMedicineBenefits and harms of BCG prevention and treatmentPatients with COVID-19MicrobiologyTechnical Report